COST-UTILITY ANALYSIS OF BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA IN COSTA RICA

被引:0
|
作者
Ordonez, J. [1 ]
Guadamuz, R. [2 ]
Monge, O. [2 ]
Ordonez, A. [1 ]
Hidalgo Godinez, J. [3 ]
Buitrago, R. [3 ]
机构
[1] True Consulting, Medellin, Ant, Colombia
[2] Caja Costarricense Seguro Social, San Jose, Costa Rica
[3] AstraZeneca CAC, San Jose, Costa Rica
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE249
引用
收藏
页码:S382 / S383
页数:2
相关论文
共 50 条
  • [1] COST-UTILITY ANALYSIS OF BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA IN PANAMA
    Ordonez, J.
    Ordonez, A.
    Hidalgo Godinez, J.
    Buitrago, R.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S422 - S423
  • [2] COST-UTILITY ANALYSIS OF BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA IN COLOMBIA
    Ordonez, J.
    Ordonez, A.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S360 - S361
  • [3] COST-UTILITY ANALYSIS OF MEPOLIZUMAB VERSUS BENRALIZUMAB FOR SEVERE EOSINOPHILIC ASTHMA IN THE COLOMBIAN HEALTHCARE SYSTEM
    Rodriguez, E.
    Garcia Nuncira, C. Y.
    [J]. VALUE IN HEALTH, 2020, 23 : S350 - S350
  • [4] Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia
    Jefferson Antonio, Buendia
    Patino, Diana Guerrero
    Lopez Moreno, Melisa
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (02) : 299 - 305
  • [5] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE IN COSTA RICA
    Ordonez, J.
    Quesada Chaves, D. F.
    Rodriguez, M.
    Poveda, J.
    Speranza, M.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S360 - S360
  • [6] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN COSTA RICA
    Ordonez, J.
    Hernandez, F.
    Rodriguez, G.
    Estrada, J.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S403 - S403
  • [7] COST-UTILITY ANALYSIS OF PNEUMOCOCCAL VACCINES FOR OLDER ADULTS AVAILABLE IN COSTA RICA
    Ordonez, J.
    Castro, Baldi J. J.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S264 - S264
  • [8] Benralizumab (Fasenra) for Severe Eosinophilic Asthma
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1541): : 33 - 35
  • [9] Cost-utility of tiotropium in patients with severe asthma
    Buendia, Jefferson Antonio
    Patino, Diana Guerrero
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2024, 22 (01)
  • [10] Cost-utility of azithromycin in patients with severe asthma
    Buendia, Jefferson Antonio
    Patino, Diana Guerrero
    Feliciano-Alfonso, John Edwin
    [J]. JOURNAL OF ASTHMA, 2022, 59 (10) : 2008 - 2015